{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:27:50Z","timestamp":1792196870552,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.phrs.2021.105801","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T06:42:35Z","timestamp":1628145755000},"page":"105801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Indacaterol, glycopyrronium, and mometasone: Pharmacological interaction and anti-inflammatory profile in hyperresponsive airways"],"prefix":"10.1016","volume":"172","author":[{"given":"Paola","family":"Rogliani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice Ludovica","family":"Ritondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Facciolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriella","family":"Matera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4501-2083","authenticated-orcid":false,"given":"Ivan","family":"Nikolaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigino","family":"Calzetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10118","key":"10.1016\/j.phrs.2021.105801_bib1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.phrs.2021.105801_bib2","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1365-2222.2009.03321.x","article-title":"The definition and diagnosis of Asthma","volume":"39","author":"Hargreave","year":"2009","journal-title":"Clin. Exp. Allergy"},{"issue":"3","key":"10.1016\/j.phrs.2021.105801_bib3","doi-asserted-by":"crossref","first-page":"411S","DOI":"10.1378\/chest.123.3_suppl.411S","article-title":"Airway hyperresponsiveness","volume":"123","author":"O\u2019Byrne","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.phrs.2021.105801_bib4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/15412555.2018.1459533","article-title":"Psychological stress, lung function and exacerbation risk in COPD: is an increase of cholinergic tone a possible link","volume":"15","author":"Liccardi","year":"2018","journal-title":"COPD"},{"issue":"2","key":"10.1016\/j.phrs.2021.105801_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ppul.23904","article-title":"Anxiety and asthma in youth. Is a stress\u2010induced increased cholinergic tone the possible link?","volume":"53","author":"Liccardi","year":"2018","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.phrs.2021.105801_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.rmed.2016.05.026","article-title":"Can bronchial asthma with an highly prevalent airway (and systemic) vagal tone be considered an independent asthma phenotype? Possible role of anticholinergics","volume":"117","author":"Liccardi","year":"2016","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.phrs.2021.105801_bib7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaip.2016.03.025","article-title":"Can an increased cholinergic tone constitute a predictor of positive response to tiotropium in patients with moderate asthma?","volume":"4","author":"Liccardi","year":"2016","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"1","key":"10.1016\/j.phrs.2021.105801_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12931-016-0386-8","article-title":"Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells","volume":"17","author":"Cazzola","year":"2016","journal-title":"Respir. Res."},{"key":"10.1016\/j.phrs.2021.105801_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coph.2014.03.001","article-title":"Non-neuronal cholinergic airway epithelium biology","volume":"16","author":"Kummer","year":"2014","journal-title":"Curr. Opin. Pharm."},{"issue":"3","key":"10.1016\/j.phrs.2021.105801_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.coph.2013.04.004","article-title":"A new perspective on muscarinic receptor antagonism in obstructive airways diseases","volume":"13","author":"Meurs","year":"2013","journal-title":"Curr. Opin. Pharm."},{"issue":"10","key":"10.1016\/j.phrs.2021.105801_bib11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S2213-2600(20)30190-9","article-title":"Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study","volume":"8","author":"Kerstjens","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"10","key":"10.1016\/j.phrs.2021.105801_bib12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S2213-2600(20)30178-8","article-title":"Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study","volume":"8","author":"van Zyl-Smit","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"10.1016\/j.phrs.2021.105801_bib13","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1165\/rcmb.2011-0056OC","article-title":"Pharmacological characterization of adenosine receptors on isolated human bronchi","volume":"45","author":"Calzetta","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105801_bib14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1165\/rcmb.2010-0306OC","article-title":"Protein prenylation contributes to the effects of LPS on EFS-induced responses in human isolated bronchi","volume":"45","author":"Cazzola","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.phrs.2021.105801_bib15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1124\/jpet.111.186379","article-title":"Preclinical evaluation of an inhibitor of cytosolic phospholipase A2\u03b1 for the treatment of asthma","volume":"340","author":"Hewson","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2021.105801_bib16","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.pupt.2009.04.005","article-title":"Relaxant effect of brain natriuretic peptide in nonsensitized and passively sensitized isolated human bronchi","volume":"22","author":"Matera","year":"2009","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.phrs.2021.105801_bib17","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/j.1476-5381.2011.01339.x","article-title":"Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi","volume":"163","author":"Matera","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105801_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pupt.2012.09.003","article-title":"Epithelial-smooth muscle cooperation is needed for brain natriuretic peptide-dependent bronchorelaxant activity","volume":"26","author":"Matera","year":"2013","journal-title":"Pulm. Pharm. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2021.105801_bib19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.pupt.2013.01.002","article-title":"The influence of propofol, remifentanil and lidocaine on the tone of human bronchial smooth muscle","volume":"26","author":"Rogliani","year":"2013","journal-title":"Pulm. Pharm. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2021.105801_bib20","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1476-5381.2010.00975.x","article-title":"Dual bronchodilatory and pulmonary anti-inflammatory activity of RO5024118, a novel agonist at vasoactive intestinal peptide VPAC2 receptors","volume":"161","author":"Tannu","year":"2010","journal-title":"Br. J. Pharm."},{"issue":"3","key":"10.1016\/j.phrs.2021.105801_bib21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/jpet.113.204644","article-title":"Effect of the mixed phosphodiesterase 3\/4 inhibitor RPL554 on human isolated bronchial smooth muscle tone","volume":"346","author":"Calzetta","year":"2013","journal-title":"J. Pharm. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2021.105801_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12931-018-0770-7","article-title":"Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways","volume":"19","author":"Calzetta","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.phrs.2021.105801_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2015.11.004","article-title":"Interaction between corticosteroids and muscarinic antagonists in human airways","volume":"36","author":"Cazzola","year":"2016","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2021.105801_bib24","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/bph.14909","article-title":"Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: synergy of triple combination therapy on human airway smooth muscle ex vivo","volume":"177","author":"Rogliani","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2021.105801_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2005.12.043","article-title":"Inhibition of Rho-kinase normalizes nonspecific hyperresponsiveness in passively sensitized airway smooth muscle preparations","volume":"531","author":"Schaafsma","year":"2006","journal-title":"Eur. J. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2021.105801_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1034\/j.1399-3003.1999.14b13.x","article-title":"Passive sensitization of human airways increases responsiveness to leukotriene C4","volume":"14","author":"Schmidt","year":"1999","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2021.105801_bib27","series-title":"D101. Clinical and Translational Studies in Asthma and COPD","article-title":"The combination of indacaterol\/glycopyrronium\/mometasone furoate is superior to high-dose salmeterol\/fluticasone propionate in improving lung function in patients with asthma","author":"Watz","year":"2019"},{"issue":"2","key":"10.1016\/j.phrs.2021.105801_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pupt.2010.12.008","article-title":"Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi","volume":"24","author":"Matera","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2021.105801_bib29","series-title":"Fitting Models to Biological Data using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting","author":"Motulsky","year":"2004"},{"issue":"5","key":"10.1016\/j.phrs.2021.105801_bib30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.tiv.2007.03.003","article-title":"A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model","volume":"21","author":"Goldoni","year":"2007","journal-title":"Toxicol. Vitr."},{"issue":"3","key":"10.1016\/j.phrs.2021.105801_bib31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.phrs.2021.105801_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.coph.2018.03.011","article-title":"Pharmacological mechanisms leading to synergy in fixed-dose dual bronchodilator therapy","volume":"40","author":"Calzetta","year":"2018","journal-title":"Curr. Opin. Pharm."},{"key":"10.1016\/j.phrs.2021.105801_bib33","unstructured":"2021 GINA Main Report - Global Initiative for Asthma - GINA. \u3008https:\/\/ginasthma.org\/gina-reports\/\u3009 (Accessed Jul. 22, 2021)."},{"issue":"9","key":"10.1016\/j.phrs.2021.105801_bib34","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/17512433.2020.1817739","article-title":"Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings","volume":"13","author":"Rogliani","year":"2020","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105801_bib35","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2147\/TCRM.S103709","article-title":"Use of ICS\/LABA (extra-fine and non-extra-fine) in elderly asthmatics","volume":"12","author":"Benfante","year":"2016","journal-title":"Ther. Clin. Risk Manag."},{"issue":"2","key":"10.1016\/j.phrs.2021.105801_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2332\/allergolint.12-RA-0523","article-title":"Influences of smoking and aging on allergic airway inflammation in asthma","volume":"62","author":"Nagasaki","year":"2013","journal-title":"Allergol. Int."},{"issue":"156","key":"10.1016\/j.phrs.2021.105801_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/16000617.0137-2019","article-title":"Minimal clinically important difference for asthma endpoints: an expert consensus report","volume":"29","author":"Bonini","year":"2020","journal-title":"Eur. Respir. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2021.105801_bib38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MCP.0b013e32835b11f6","article-title":"Asthma outcomes revisited","volume":"19","author":"Parulekar","year":"2013","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.phrs.2021.105801_bib39","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ejphar.2015.04.042","article-title":"Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi","volume":"761","author":"Rogliani","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105801_bib40","article-title":"Small airways in asthma: from bench-to-bedside","author":"Calzetta","year":"2021","journal-title":"Minerva Med."},{"key":"10.1016\/j.phrs.2021.105801_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106021","article-title":"Fixed-dose combination of indacaterol\/glycopyrronium\/mometasone furoate once-daily versus salmeterol\/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: a randomised, Phase IIIb, non-inferiority study (ARGON)","volume":"170","author":"Gessner","year":"2020","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.phrs.2021.105801_bib42","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.immuni.2019.03.018","article-title":"The cytokines of asthma","volume":"50","author":"Lambrecht","year":"2019","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.phrs.2021.105801_bib43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1398-9995.2000.00112.x","article-title":"Role of tachykinins in asthma","volume":"55","author":"Joos","year":"2000","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.phrs.2021.105801_bib44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/187152807780832238","article-title":"Neurogenic inflammation and asthma","volume":"6","author":"Butler","year":"2007","journal-title":"Inflamm. Allergy-Drug Targets"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2021.105801_bib45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0034-5687(00)00210-3","article-title":"Neurogenic inflammation in the airways","volume":"125","author":"Barnes","year":"2001","journal-title":"Respir. Physiol."},{"issue":"11","key":"10.1016\/j.phrs.2021.105801_bib46","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1398-9995.2004.00665.x","article-title":"Neurogenic mechanisms in bronchial inflammatory diseases","volume":"59","author":"Groneberg","year":"2004","journal-title":"Allergy"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821003856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821003856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:28:07Z","timestamp":1760912887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821003856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":46,"alternative-id":["S1043661821003856"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105801","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indacaterol, glycopyrronium, and mometasone: Pharmacological interaction and anti-inflammatory profile in hyperresponsive airways","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105801"}}